메뉴 건너뛰기




Volumn 74, Issue , 2016, Pages 73-84

Immunomodulators in SLE: Clinical evidence and immunologic actions

Author keywords

Belimumab; Dehydroeipandrosterone; Hydroxychloroquine; Immunomodulation; SLE; Vitamin D

Indexed keywords

ANDROGEN; BELIMUMAB; DEHYDROEIPANDROSTERONE; HYDROXYCHLOROQUINE; IMMUNOMODULATING AGENT; PRASTERONE; UNCLASSIFIED DRUG; VITAMIN D; IMMUNOLOGIC FACTOR; IMMUNOLOGICAL ADJUVANT;

EID: 84979663395     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2016.06.010     Document Type: Review
Times cited : (65)

References (148)
  • 1
    • 84953238452 scopus 로고    scopus 로고
    • Towards new avenues in the management of lupus glomerulonephritis
    • Apr
    • [1] Mok, C.C., Towards new avenues in the management of lupus glomerulonephritis. Nat. Rev. Rheumatol. 12:4 (2016 Apr), 221–234, 10.1038/nrrheum.2015.
    • (2016) Nat. Rev. Rheumatol. , vol.12 , Issue.4 , pp. 221-234
    • Mok, C.C.1
  • 2
    • 0034645414 scopus 로고    scopus 로고
    • Changes in the incidence of end-stage renal disease due to lupus nephritis, 1982-1995
    • [2] Ward, M.M., Changes in the incidence of end-stage renal disease due to lupus nephritis, 1982-1995. Arch. Intern Med. 160:20 (2000), 3136–3140.
    • (2000) Arch. Intern Med. , vol.160 , Issue.20 , pp. 3136-3140
    • Ward, M.M.1
  • 3
    • 0026077614 scopus 로고
    • Control of adrenal androgen secretion
    • [3] Parker, L.N., Control of adrenal androgen secretion. Endocrinol. Metab. Clin. North Am. 20:2 (1991), 401–421.
    • (1991) Endocrinol. Metab. Clin. North Am. , vol.20 , Issue.2 , pp. 401-421
    • Parker, L.N.1
  • 4
    • 11144329546 scopus 로고    scopus 로고
    • Adrenal androgens and the immune system
    • [4] Chen, C.C., Parker, C.R., Adrenal androgens and the immune system. Semin. Reprod. Med. 22:4 (2004), 369–377.
    • (2004) Semin. Reprod. Med. , vol.22 , Issue.4 , pp. 369-377
    • Chen, C.C.1    Parker, C.R.2
  • 5
    • 33646675132 scopus 로고    scopus 로고
    • The biological actions of dehydroepiandrosterone involves multiple receptors
    • [5] Webb, S.J., Geoghegan, T.E., Prough, R.A., Michael Miller, K.K., The biological actions of dehydroepiandrosterone involves multiple receptors. Drug Metab. Rev. 38:1–2 (2006), 89–116.
    • (2006) Drug Metab. Rev. , vol.38 , Issue.1-2 , pp. 89-116
    • Webb, S.J.1    Geoghegan, T.E.2    Prough, R.A.3    Michael Miller, K.K.4
  • 6
    • 0031835941 scopus 로고    scopus 로고
    • Dehydroepiandrosterone (DHEA) and systemic lupus erythematosus
    • [6] Derksen, R.H., Dehydroepiandrosterone (DHEA) and systemic lupus erythematosus. Semin. Arthritis Rheum. 27:6 (1998), 335–347.
    • (1998) Semin. Arthritis Rheum. , vol.27 , Issue.6 , pp. 335-347
    • Derksen, R.H.1
  • 8
    • 84888380305 scopus 로고    scopus 로고
    • Genome-wide association studies on serum sex steroid levels
    • [8] Vandenput, L., Ohlsson, C., Genome-wide association studies on serum sex steroid levels. Mol. Cell Endocrinol. 382:1 (2014), 758–766.
    • (2014) Mol. Cell Endocrinol. , vol.382 , Issue.1 , pp. 758-766
    • Vandenput, L.1    Ohlsson, C.2
  • 9
    • 80155149402 scopus 로고    scopus 로고
    • Dehydroepiandrosterone (DHEA)–a precursor steroid or an active hormone in human physiology
    • quiz 83
    • [9] Traish, A.M., Kang, H.P., Saad, F., Guay, A.T., Dehydroepiandrosterone (DHEA)–a precursor steroid or an active hormone in human physiology. J. Sex. Med. 8:11 (2011), 2960–2982 quiz 83.
    • (2011) J. Sex. Med. , vol.8 , Issue.11 , pp. 2960-2982
    • Traish, A.M.1    Kang, H.P.2    Saad, F.3    Guay, A.T.4
  • 10
    • 26844434734 scopus 로고    scopus 로고
    • Direct agonist/antagonist functions of dehydroepiandrosterone
    • [10] Chen, F., Knecht, K., Birzin, E., Fisher, J., Wilkinson, H., Mojena, M., et al. Direct agonist/antagonist functions of dehydroepiandrosterone. Endocrinology 146:11 (2005), 4568–4576.
    • (2005) Endocrinology , vol.146 , Issue.11 , pp. 4568-4576
    • Chen, F.1    Knecht, K.2    Birzin, E.3    Fisher, J.4    Wilkinson, H.5    Mojena, M.6
  • 11
    • 0036236065 scopus 로고    scopus 로고
    • Induction of CYP3A expression by dehydroepiandrosterone: involvement of the pregnane X receptor
    • [11] Ripp, S.L., Fitzpatrick, J.L., Peters, J.M., Prough, R.A., Induction of CYP3A expression by dehydroepiandrosterone: involvement of the pregnane X receptor. Drug Metab. Dispos. 30:5 (2002), 570–575.
    • (2002) Drug Metab. Dispos. , vol.30 , Issue.5 , pp. 570-575
    • Ripp, S.L.1    Fitzpatrick, J.L.2    Peters, J.M.3    Prough, R.A.4
  • 15
    • 0042574010 scopus 로고    scopus 로고
    • Sex hormones and systemic lupus erythematosus: review and meta-analysis
    • [15] McMurray, R.W., May, W., Sex hormones and systemic lupus erythematosus: review and meta-analysis. Arthritis Rheum. 48:8 (2003), 2100–2110.
    • (2003) Arthritis Rheum. , vol.48 , Issue.8 , pp. 2100-2110
    • McMurray, R.W.1    May, W.2
  • 16
    • 0023261410 scopus 로고
    • Low plasma androgens in women with systemic lupus erythematosus
    • [16] Lahita, R.G., Bradlow, H.L., Ginzler, E., Pang, S., New, M., Low plasma androgens in women with systemic lupus erythematosus. Arthritis Rheum. 30:3 (1987), 241–248.
    • (1987) Arthritis Rheum. , vol.30 , Issue.3 , pp. 241-248
    • Lahita, R.G.1    Bradlow, H.L.2    Ginzler, E.3    Pang, S.4    New, M.5
  • 17
    • 0028962459 scopus 로고
    • Low serum levels of dehydroepiandrosterone may cause deficient IL-2 production by lymphocytes in patients with systemic lupus erythematosus (SLE)
    • [17] Suzuki, T., Suzuki, N., Engleman, E.G., Mizushima, Y., Sakane, T., Low serum levels of dehydroepiandrosterone may cause deficient IL-2 production by lymphocytes in patients with systemic lupus erythematosus (SLE). Clin. Exp. Immunol. 99:2 (1995), 251–255.
    • (1995) Clin. Exp. Immunol. , vol.99 , Issue.2 , pp. 251-255
    • Suzuki, T.1    Suzuki, N.2    Engleman, E.G.3    Mizushima, Y.4    Sakane, T.5
  • 19
    • 73749083096 scopus 로고    scopus 로고
    • Neurocognitive deficits in schizophrenia are associated with alterations in blood levels of neurosteroids: a multiple regression analysis of findings from a double-blind, randomized, placebo-controlled, crossover trial with DHEA
    • [19] Ritsner, M.S., Strous, R.D., Neurocognitive deficits in schizophrenia are associated with alterations in blood levels of neurosteroids: a multiple regression analysis of findings from a double-blind, randomized, placebo-controlled, crossover trial with DHEA. J. Psychiatr. Res. 44:2 (2010), 75–80.
    • (2010) J. Psychiatr. Res. , vol.44 , Issue.2 , pp. 75-80
    • Ritsner, M.S.1    Strous, R.D.2
  • 20
    • 33847048555 scopus 로고    scopus 로고
    • Analysis of clinical symptomatology, extrapyramidal symptoms and neurocognitive dysfunction following dehydroepiandrosterone (DHEA) administration in olanzapine treated schizophrenia patients: a randomized, double-blind placebo controlled trial
    • [20] Strous, R.D., Stryjer, R., Maayan, R., Gal, G., Viglin, D., Katz, E., et al. Analysis of clinical symptomatology, extrapyramidal symptoms and neurocognitive dysfunction following dehydroepiandrosterone (DHEA) administration in olanzapine treated schizophrenia patients: a randomized, double-blind placebo controlled trial. Psychoneuroendocrinology 32:2 (2007), 96–105.
    • (2007) Psychoneuroendocrinology , vol.32 , Issue.2 , pp. 96-105
    • Strous, R.D.1    Stryjer, R.2    Maayan, R.3    Gal, G.4    Viglin, D.5    Katz, E.6
  • 21
    • 21044436622 scopus 로고    scopus 로고
    • Dehydroepiandrosterone, dehydroepiandrosterone sulfate and related steroids: their role in inflammatory, allergic and immunological disorders
    • [21] Dillon, J.S., Dehydroepiandrosterone, dehydroepiandrosterone sulfate and related steroids: their role in inflammatory, allergic and immunological disorders. Curr. Drug Targets Inflamm. Allergy 4:3 (2005), 377–385.
    • (2005) Curr. Drug Targets Inflamm. Allergy , vol.4 , Issue.3 , pp. 377-385
    • Dillon, J.S.1
  • 22
    • 9644269013 scopus 로고    scopus 로고
    • Dehydroepiandrosterone suppresses interleukin 10 synthesis in women with systemic lupus erythematosus
    • [22] Chang, D.M., Chu, S.J., Chen, H.C., Kuo, S.Y., Lai, J.H., Dehydroepiandrosterone suppresses interleukin 10 synthesis in women with systemic lupus erythematosus. Ann. Rheum. Dis. 63:12 (2004), 1623–1626.
    • (2004) Ann. Rheum. Dis. , vol.63 , Issue.12 , pp. 1623-1626
    • Chang, D.M.1    Chu, S.J.2    Chen, H.C.3    Kuo, S.Y.4    Lai, J.H.5
  • 23
    • 0021972642 scopus 로고
    • Prevention of autoantibody formation and prolonged survival in New Zealand black/New Zealand white F1 mice fed dehydroisoandrosterone
    • [23] Lucas, J.A., Ahmed, S.A., Casey, M.L., MacDonald, P.C., Prevention of autoantibody formation and prolonged survival in New Zealand black/New Zealand white F1 mice fed dehydroisoandrosterone. J. Clin. Invest 75:6 (1985), 2091–2093.
    • (1985) J. Clin. Invest , vol.75 , Issue.6 , pp. 2091-2093
    • Lucas, J.A.1    Ahmed, S.A.2    Casey, M.L.3    MacDonald, P.C.4
  • 24
    • 0031452895 scopus 로고    scopus 로고
    • Administration of dehydroepiandrosterone sulfate retards onset but not progression of autoimmune disease in NZB/W mice
    • [24] Norton, S.D., Harrison, L.L., Yowell, R., Araneo, B.A., Administration of dehydroepiandrosterone sulfate retards onset but not progression of autoimmune disease in NZB/W mice. Autoimmunity 26:3 (1997), 161–171.
    • (1997) Autoimmunity , vol.26 , Issue.3 , pp. 161-171
    • Norton, S.D.1    Harrison, L.L.2    Yowell, R.3    Araneo, B.A.4
  • 25
    • 0036210456 scopus 로고    scopus 로고
    • Dehydroepiandrosterone in relation to other adrenal hormones during an acute inflammatory stressful disease state compared with chronic inflammatory disease: role of interleukin-6 and tumour necrosis factor
    • [25] Straub, R.H., Lehle, K., Herfarth, H., Weber, M., Falk, W., Preuner, J., et al. Dehydroepiandrosterone in relation to other adrenal hormones during an acute inflammatory stressful disease state compared with chronic inflammatory disease: role of interleukin-6 and tumour necrosis factor. Eur. J. Endocrinol. 146:3 (2002), 365–374.
    • (2002) Eur. J. Endocrinol. , vol.146 , Issue.3 , pp. 365-374
    • Straub, R.H.1    Lehle, K.2    Herfarth, H.3    Weber, M.4    Falk, W.5    Preuner, J.6
  • 26
    • 0030457978 scopus 로고    scopus 로고
    • Serum and urinary interleukin-6 in systemic lupus erythematosus
    • [26] Peterson, E., Robertson, A.D., Emlen, W., Serum and urinary interleukin-6 in systemic lupus erythematosus. Lupus 5:6 (1996), 571–575.
    • (1996) Lupus , vol.5 , Issue.6 , pp. 571-575
    • Peterson, E.1    Robertson, A.D.2    Emlen, W.3
  • 27
    • 0027237857 scopus 로고
    • Urinary levels of IL-6 in patients with active lupus nephritis
    • [27] Iwano, M., Dohi, K., Hirata, E., Kurumatani, N., Horii, Y., Shiiki, H., et al. Urinary levels of IL-6 in patients with active lupus nephritis. Clin. Nephrol. 40:1 (1993), 16–21.
    • (1993) Clin. Nephrol. , vol.40 , Issue.1 , pp. 16-21
    • Iwano, M.1    Dohi, K.2    Hirata, E.3    Kurumatani, N.4    Horii, Y.5    Shiiki, H.6
  • 28
    • 84890508411 scopus 로고    scopus 로고
    • Plasma IL-6 levels correlate with clinical and ultrasound measures of arthritis in patients with systemic lupus erythematosus
    • [28] Ball, E.M., Gibson, D.S., Bell, A.L., Rooney, M.R., Plasma IL-6 levels correlate with clinical and ultrasound measures of arthritis in patients with systemic lupus erythematosus. Lupus 23:1 (2014), 46–56.
    • (2014) Lupus , vol.23 , Issue.1 , pp. 46-56
    • Ball, E.M.1    Gibson, D.S.2    Bell, A.L.3    Rooney, M.R.4
  • 29
    • 0037214074 scopus 로고    scopus 로고
    • Immune complexes from SLE sera induce IL10 production from normal peripheral blood mononuclear cells by an FcgammaRII dependent mechanism: implications for a possible vicious cycle maintaining B cell hyperactivity in SLE
    • [29] Rönnelid, J., Tejde, A., Mathsson, L., Nilsson-Ekdahl, K., Nilsson, B., Immune complexes from SLE sera induce IL10 production from normal peripheral blood mononuclear cells by an FcgammaRII dependent mechanism: implications for a possible vicious cycle maintaining B cell hyperactivity in SLE. Ann. Rheum. Dis. 62:1 (2003), 37–42.
    • (2003) Ann. Rheum. Dis. , vol.62 , Issue.1 , pp. 37-42
    • Rönnelid, J.1    Tejde, A.2    Mathsson, L.3    Nilsson-Ekdahl, K.4    Nilsson, B.5
  • 30
    • 0028081726 scopus 로고
    • An open study of dehydroepiandrosterone in systemic lupus erythematosus
    • [30] van Vollenhoven, R.F., Engleman, E.G., McGuire, J.L., An open study of dehydroepiandrosterone in systemic lupus erythematosus. Arthritis Rheum. 37:9 (1994), 1305–1310.
    • (1994) Arthritis Rheum. , vol.37 , Issue.9 , pp. 1305-1310
    • van Vollenhoven, R.F.1    Engleman, E.G.2    McGuire, J.L.3
  • 31
    • 0032918390 scopus 로고    scopus 로고
    • A double-blind, placebo-controlled, clinical trial of dehydroepiandrosterone in severe systemic lupus erythematosus
    • [31] van Vollenhoven, R.F., Park, J.L., Genovese, M.C., West, J.P., McGuire, J.L., A double-blind, placebo-controlled, clinical trial of dehydroepiandrosterone in severe systemic lupus erythematosus. Lupus 8:3 (1999), 181–187.
    • (1999) Lupus , vol.8 , Issue.3 , pp. 181-187
    • van Vollenhoven, R.F.1    Park, J.L.2    Genovese, M.C.3    West, J.P.4    McGuire, J.L.5
  • 32
    • 0036067464 scopus 로고    scopus 로고
    • Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial
    • [32] Petri, M.A., Lahita, R.G., Van Vollenhoven, R.F., Merrill, J.T., Schiff, M., Ginzler, E.M., et al. Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial. Arthritis Rheum. 46:7 (2002), 1820–1829.
    • (2002) Arthritis Rheum. , vol.46 , Issue.7 , pp. 1820-1829
    • Petri, M.A.1    Lahita, R.G.2    Van Vollenhoven, R.F.3    Merrill, J.T.4    Schiff, M.5    Ginzler, E.M.6
  • 33
    • 0036845197 scopus 로고    scopus 로고
    • Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus: a multicenter randomized, double-blind, placebo-controlled trial
    • [33] Chang, D.M., Lan, J.L., Lin, H.Y., Luo, S.F., Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus: a multicenter randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 46:11 (2002), 2924–2927.
    • (2002) Arthritis Rheum. , vol.46 , Issue.11 , pp. 2924-2927
    • Chang, D.M.1    Lan, J.L.2    Lin, H.Y.3    Luo, S.F.4
  • 34
    • 8444220100 scopus 로고    scopus 로고
    • The effect of dehydroepiandrosterone on lumbar spine bone mineral density in patients with quiescent systemic lupus erythematosus
    • [34] Hartkamp, A., Geenen, R., Godaert, G.L., Bijl, M., Bijlsma, J.W., Derksen, R.H., The effect of dehydroepiandrosterone on lumbar spine bone mineral density in patients with quiescent systemic lupus erythematosus. Arthritis Rheum. 50:11 (2004), 3591–3595.
    • (2004) Arthritis Rheum. , vol.50 , Issue.11 , pp. 3591-3595
    • Hartkamp, A.1    Geenen, R.2    Godaert, G.L.3    Bijl, M.4    Bijlsma, J.W.5    Derksen, R.H.6
  • 35
    • 20244364828 scopus 로고    scopus 로고
    • Effects of prasterone on bone mineral density in women with systemic lupus erythematosus receiving chronic glucocorticoid therapy
    • [35] Mease, P.J., Ginzler, E.M., Gluck, O.S., Schiff, M., Goldman, A., Greenwald, M., et al. Effects of prasterone on bone mineral density in women with systemic lupus erythematosus receiving chronic glucocorticoid therapy. J. Rheumatol. 32:4 (2005), 616–621.
    • (2005) J. Rheumatol. , vol.32 , Issue.4 , pp. 616-621
    • Mease, P.J.1    Ginzler, E.M.2    Gluck, O.S.3    Schiff, M.4    Goldman, A.5    Greenwald, M.6
  • 36
    • 49049112006 scopus 로고    scopus 로고
    • Effects of prasterone on bone mineral density in women with active systemic lupus erythematosus receiving chronic glucocorticoid therapy
    • [36] Sánchez-Guerrero, J., Fragoso-Loyo, H.E., Neuwelt, C.M., Wallace, D.J., Ginzler, E.M., Sherrer, Y.R., et al. Effects of prasterone on bone mineral density in women with active systemic lupus erythematosus receiving chronic glucocorticoid therapy. J. Rheumatol. 35:8 (2008), 1567–1575.
    • (2008) J. Rheumatol. , vol.35 , Issue.8 , pp. 1567-1575
    • Sánchez-Guerrero, J.1    Fragoso-Loyo, H.E.2    Neuwelt, C.M.3    Wallace, D.J.4    Ginzler, E.M.5    Sherrer, Y.R.6
  • 37
    • 30844446256 scopus 로고    scopus 로고
    • Effects of dehydroepiandrosterone supplement on health-related quality of life in glucocorticoid treated female patients with systemic lupus erythematosus
    • [37] Nordmark, G., Bengtsson, C., Larsson, A., Karlsson, F.A., Sturfelt, G., Rönnblom, L., Effects of dehydroepiandrosterone supplement on health-related quality of life in glucocorticoid treated female patients with systemic lupus erythematosus. Autoimmunity 38:7 (2005), 531–540.
    • (2005) Autoimmunity , vol.38 , Issue.7 , pp. 531-540
    • Nordmark, G.1    Bengtsson, C.2    Larsson, A.3    Karlsson, F.A.4    Sturfelt, G.5    Rönnblom, L.6
  • 38
    • 0031007301 scopus 로고    scopus 로고
    • The reliability of the systemic lupus international collaborating clinics/american College of Rheumatology damage index in patients with systemic lupus erythematosus
    • [38] Gladman, D.D., Urowitz, M.B., Goldsmith, C.H., Fortin, P., Ginzler, E., Gordon, C., et al. The reliability of the systemic lupus international collaborating clinics/american College of Rheumatology damage index in patients with systemic lupus erythematosus. Arthritis Rheum. 40:5 (1997), 809–813.
    • (1997) Arthritis Rheum. , vol.40 , Issue.5 , pp. 809-813
    • Gladman, D.D.1    Urowitz, M.B.2    Goldsmith, C.H.3    Fortin, P.4    Ginzler, E.5    Gordon, C.6
  • 39
    • 2642522980 scopus 로고    scopus 로고
    • The discovery of vitamin D: the contribution of Adolf Windaus
    • [39] Wolf, G., The discovery of vitamin D: the contribution of Adolf Windaus. J. Nutr. 134:6 (2004), 1299–1302.
    • (2004) J. Nutr. , vol.134 , Issue.6 , pp. 1299-1302
    • Wolf, G.1
  • 41
    • 34447514029 scopus 로고    scopus 로고
    • Vitamin D deficiency
    • [41] Holick, M.F., Vitamin D deficiency. N. Engl. J. Med. 357:3 (2007), 266–281.
    • (2007) N. Engl. J. Med. , vol.357 , Issue.3 , pp. 266-281
    • Holick, M.F.1
  • 42
    • 16244418604 scopus 로고    scopus 로고
    • Overview of general physiologic features and functions of vitamin D
    • [42] DeLuca, H.F., Overview of general physiologic features and functions of vitamin D. Am. J. Clin. Nutr. 80:6 Suppl (2004), 1689S–1696S.
    • (2004) Am. J. Clin. Nutr. , vol.80 , Issue.6 , pp. 1689S-1696S
    • DeLuca, H.F.1
  • 43
    • 84949543188 scopus 로고    scopus 로고
    • Immune response modulation by vitamin D: role in systemic lupus erythematosus
    • [43] Iruretagoyena, M., Hirigoyen, D., Naves, R., Burgos, P.I., Immune response modulation by vitamin D: role in systemic lupus erythematosus. Front. Immunol., 6, 2015, 513.
    • (2015) Front. Immunol. , vol.6 , pp. 513
    • Iruretagoyena, M.1    Hirigoyen, D.2    Naves, R.3    Burgos, P.I.4
  • 44
    • 78650886291 scopus 로고    scopus 로고
    • The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know
    • [44] Ross, A.C., Manson, J.E., Abrams, S.A., Aloia, J.F., Brannon, P.M., Clinton, S.K., et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J. Clin. Endocrinol. Metab. 96:1 (2011), 53–58.
    • (2011) J. Clin. Endocrinol. Metab. , vol.96 , Issue.1 , pp. 53-58
    • Ross, A.C.1    Manson, J.E.2    Abrams, S.A.3    Aloia, J.F.4    Brannon, P.M.5    Clinton, S.K.6
  • 45
    • 77956182419 scopus 로고    scopus 로고
    • Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: recommendations for clinical practice
    • [45] Souberbielle, J.C., Body, J.J., Lappe, J.M., Plebani, M., Shoenfeld, Y., Wang, T.J., et al. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: recommendations for clinical practice. Autoimmun. Rev. 9:11 (2010), 709–715.
    • (2010) Autoimmun. Rev. , vol.9 , Issue.11 , pp. 709-715
    • Souberbielle, J.C.1    Body, J.J.2    Lappe, J.M.3    Plebani, M.4    Shoenfeld, Y.5    Wang, T.J.6
  • 46
    • 27644454006 scopus 로고    scopus 로고
    • Vitamin D: important for prevention of osteoporosis, cardiovascular heart disease, type 1 diabetes, autoimmune diseases, and some cancers
    • [46] Holick, M.F., Vitamin D: important for prevention of osteoporosis, cardiovascular heart disease, type 1 diabetes, autoimmune diseases, and some cancers. South Med. J. 98:10 (2005), 1024–1027.
    • (2005) South Med. J. , vol.98 , Issue.10 , pp. 1024-1027
    • Holick, M.F.1
  • 47
    • 77952314178 scopus 로고    scopus 로고
    • Vitamin D and multiple sclerosis
    • [47] Ascherio, A., Munger, K.L., Simon, K.C., Vitamin D and multiple sclerosis. Lancet Neurol. 9:6 (2010), 599–612.
    • (2010) Lancet Neurol. , vol.9 , Issue.6 , pp. 599-612
    • Ascherio, A.1    Munger, K.L.2    Simon, K.C.3
  • 48
    • 34547421856 scopus 로고    scopus 로고
    • Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis
    • [48] Patel, S., Farragher, T., Berry, J., Bunn, D., Silman, A., Symmons, D., Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis. Arthritis Rheum. 56:7 (2007), 2143–2149.
    • (2007) Arthritis Rheum. , vol.56 , Issue.7 , pp. 2143-2149
    • Patel, S.1    Farragher, T.2    Berry, J.3    Bunn, D.4    Silman, A.5    Symmons, D.6
  • 49
    • 0028980323 scopus 로고
    • Vitamin D3 metabolism in patients with rheumatic diseases: low serum levels of 25-hydroxyvitamin D3 in patients with systemic lupus erythematosus
    • [49] Müller, K., Kriegbaum, N.J., Baslund, B., Sørensen, O.H., Thymann, M., Bentzen, K., Vitamin D3 metabolism in patients with rheumatic diseases: low serum levels of 25-hydroxyvitamin D3 in patients with systemic lupus erythematosus. Clin. Rheumatol. 14:4 (1995), 397–400.
    • (1995) Clin. Rheumatol. , vol.14 , Issue.4 , pp. 397-400
    • Müller, K.1    Kriegbaum, N.J.2    Baslund, B.3    Sørensen, O.H.4    Thymann, M.5    Bentzen, K.6
  • 50
    • 80051475298 scopus 로고    scopus 로고
    • Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus
    • [50] Ritterhouse, L.L., Crowe, S.R., Niewold, T.B., Kamen, D.L., Macwana, S.R., Roberts, V.C., et al. Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus. Ann. Rheum. Dis. 70:9 (2011), 1569–1574.
    • (2011) Ann. Rheum. Dis. , vol.70 , Issue.9 , pp. 1569-1574
    • Ritterhouse, L.L.1    Crowe, S.R.2    Niewold, T.B.3    Kamen, D.L.4    Macwana, S.R.5    Roberts, V.C.6
  • 51
    • 67651085514 scopus 로고    scopus 로고
    • Hypovitaminosis D is associated with greater body mass index and disease activity in pediatric systemic lupus erythematosus
    • [51] Wright, T.B., Shults, J., Leonard, M.B., Zemel, B.S., Burnham, J.M., Hypovitaminosis D is associated with greater body mass index and disease activity in pediatric systemic lupus erythematosus. J. Pediatr. 155:2 (2009), 260–265.
    • (2009) J. Pediatr. , vol.155 , Issue.2 , pp. 260-265
    • Wright, T.B.1    Shults, J.2    Leonard, M.B.3    Zemel, B.S.4    Burnham, J.M.5
  • 53
    • 0034759540 scopus 로고    scopus 로고
    • Vitamin D levels in women with systemic lupus erythematosus and fibromyalgia
    • [53] Huisman, A.M., White, K.P., Algra, A., Harth, M., Vieth, R., Jacobs, J.W., et al. Vitamin D levels in women with systemic lupus erythematosus and fibromyalgia. J. Rheumatol. 28:11 (2001), 2535–2539.
    • (2001) J. Rheumatol. , vol.28 , Issue.11 , pp. 2535-2539
    • Huisman, A.M.1    White, K.P.2    Algra, A.3    Harth, M.4    Vieth, R.5    Jacobs, J.W.6
  • 54
    • 33750499270 scopus 로고    scopus 로고
    • Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus
    • [54] Ruiz-Irastorza, G., Egurbide, M.V., Pijoan, J.I., Garmendia, M., Villar, I., Martinez-Berriotxoa, A., et al. Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus. Lupus 15:9 (2006), 577–583.
    • (2006) Lupus , vol.15 , Issue.9 , pp. 577-583
    • Ruiz-Irastorza, G.1    Egurbide, M.V.2    Pijoan, J.I.3    Garmendia, M.4    Villar, I.5    Martinez-Berriotxoa, A.6
  • 55
    • 84877268917 scopus 로고    scopus 로고
    • Vitamin D and systemic lupus erythematosus: an update
    • [55] Mok, C.C., Vitamin D and systemic lupus erythematosus: an update. Expert Rev. Clin. Immunol. 9:5 (2013), 453–463.
    • (2013) Expert Rev. Clin. Immunol. , vol.9 , Issue.5 , pp. 453-463
    • Mok, C.C.1
  • 56
    • 84889813182 scopus 로고    scopus 로고
    • Vitamin D-binding protein and vitamin D status of black Americans and white Americans
    • [56] Powe, C.E., Evans, M.K., Wenger, J., Zonderman, A.B., Berg, A.H., Nalls, M., et al. Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N. Engl. J. Med. 369:21 (2013), 1991–2000.
    • (2013) N. Engl. J. Med. , vol.369 , Issue.21 , pp. 1991-2000
    • Powe, C.E.1    Evans, M.K.2    Wenger, J.3    Zonderman, A.B.4    Berg, A.H.5    Nalls, M.6
  • 57
    • 84870540921 scopus 로고    scopus 로고
    • Dietary intake of vitamin D during adolescence and risk of adult-onset systemic lupus erythematosus and rheumatoid arthritis
    • [57] Hiraki, L.T., Munger, K.L., Costenbader, K.H., Karlson, E.W., Dietary intake of vitamin D during adolescence and risk of adult-onset systemic lupus erythematosus and rheumatoid arthritis. Arthritis Care Res. Hob. 64:12 (2012), 1829–1836.
    • (2012) Arthritis Care Res. Hob. , vol.64 , Issue.12 , pp. 1829-1836
    • Hiraki, L.T.1    Munger, K.L.2    Costenbader, K.H.3    Karlson, E.W.4
  • 58
    • 34548637038 scopus 로고    scopus 로고
    • Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation
    • [58] Chen, S., Sims, G.P., Chen, X.X., Gu, Y.Y., Lipsky, P.E., Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J. Immunol. 179:3 (2007), 1634–1647.
    • (2007) J. Immunol. , vol.179 , Issue.3 , pp. 1634-1647
    • Chen, S.1    Sims, G.P.2    Chen, X.X.3    Gu, Y.Y.4    Lipsky, P.E.5
  • 59
    • 84856469462 scopus 로고    scopus 로고
    • Vitamin D and the immune system
    • [59] Aranow, C., Vitamin D and the immune system. J. Investig. Med. 59:6 (2011), 881–886.
    • (2011) J. Investig. Med. , vol.59 , Issue.6 , pp. 881-886
    • Aranow, C.1
  • 60
    • 84880334803 scopus 로고    scopus 로고
    • Vitamin D deficiency impacts on expression of toll-like receptor-2 and cytokine profile: a pilot study
    • [60] Ojaimi, S., Skinner, N.A., Strauss, B.J., Sundararajan, V., Woolley, I., Visvanathan, K., Vitamin D deficiency impacts on expression of toll-like receptor-2 and cytokine profile: a pilot study. J. Transl. Med., 11, 2013, 176.
    • (2013) J. Transl. Med. , vol.11 , pp. 176
    • Ojaimi, S.1    Skinner, N.A.2    Strauss, B.J.3    Sundararajan, V.4    Woolley, I.5    Visvanathan, K.6
  • 61
    • 54049135639 scopus 로고    scopus 로고
    • Myeloid dendritic cells display downregulation of C-type lectin receptors and aberrant lectin uptake in systemic lupus erythematosus
    • [61] Monrad, S.U., Rea, K., Thacker, S., Kaplan, M.J., Myeloid dendritic cells display downregulation of C-type lectin receptors and aberrant lectin uptake in systemic lupus erythematosus. Arthritis Res. Ther., 10(5), 2008, R114.
    • (2008) Arthritis Res. Ther. , vol.10 , Issue.5 , pp. R114
    • Monrad, S.U.1    Rea, K.2    Thacker, S.3    Kaplan, M.J.4
  • 62
    • 77949538186 scopus 로고    scopus 로고
    • The impact of vitamin D on dendritic cell function in patients with systemic lupus erythematosus
    • [62] Ben-Zvi, I., Aranow, C., Mackay, M., Stanevsky, A., Kamen, D.L., Marinescu, L.M., et al. The impact of vitamin D on dendritic cell function in patients with systemic lupus erythematosus. PLoS One, 5(2), 2010, e9193.
    • (2010) PLoS One , vol.5 , Issue.2 , pp. e9193
    • Ben-Zvi, I.1    Aranow, C.2    Mackay, M.3    Stanevsky, A.4    Kamen, D.L.5    Marinescu, L.M.6
  • 63
    • 84933037300 scopus 로고    scopus 로고
    • Randomized, double-blind, placebo-controlled trial of the effect of vitamin D3 on the interferon signature in patients with systemic lupus erythematosus
    • [63] Aranow, C., Kamen, D.L., Dall'Era, M., Massarotti, E.M., Mackay, M.C., Koumpouras, F., et al. Randomized, double-blind, placebo-controlled trial of the effect of vitamin D3 on the interferon signature in patients with systemic lupus erythematosus. Arthritis Rheumatol. 67:7 (2015), 1848–1857.
    • (2015) Arthritis Rheumatol. , vol.67 , Issue.7 , pp. 1848-1857
    • Aranow, C.1    Kamen, D.L.2    Dall'Era, M.3    Massarotti, E.M.4    Mackay, M.C.5    Koumpouras, F.6
  • 65
    • 77953716994 scopus 로고    scopus 로고
    • Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D?
    • [65] Amital, H., Szekanecz, Z., Szücs, G., Dankó, K., Nagy, E., Csépány, T., et al. Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D?. Ann. Rheum. Dis. 69:6 (2010), 1155–1157.
    • (2010) Ann. Rheum. Dis. , vol.69 , Issue.6 , pp. 1155-1157
    • Amital, H.1    Szekanecz, Z.2    Szücs, G.3    Dankó, K.4    Nagy, E.5    Csépány, T.6
  • 66
    • 84857058008 scopus 로고    scopus 로고
    • Vitamin D levels: its relationship to bone mineral density response and disease activity in premenopausal Malaysian systemic lupus erythematosus patients on corticosteroids
    • [66] Yeap, S.S., Othman, A.Z., Zain, A.A., Chan, S.P., Vitamin D levels: its relationship to bone mineral density response and disease activity in premenopausal Malaysian systemic lupus erythematosus patients on corticosteroids. Int. J. Rheum. Dis. 15:1 (2012), 17–24.
    • (2012) Int. J. Rheum. Dis. , vol.15 , Issue.1 , pp. 17-24
    • Yeap, S.S.1    Othman, A.Z.2    Zain, A.A.3    Chan, S.P.4
  • 67
    • 84857543005 scopus 로고    scopus 로고
    • 25-Hydroxyvitamin D deficiency is associated with increased aortic stiffness in patients with systemic lupus erythematosus
    • [67] Reynolds, J.A., Haque, S., Berry, J.L., Pemberton, P., Teh, L.S., Ho, P., et al. 25-Hydroxyvitamin D deficiency is associated with increased aortic stiffness in patients with systemic lupus erythematosus. Rheumatol. Oxf. 51:3 (2012), 544–551.
    • (2012) Rheumatol. Oxf. , vol.51 , Issue.3 , pp. 544-551
    • Reynolds, J.A.1    Haque, S.2    Berry, J.L.3    Pemberton, P.4    Teh, L.S.5    Ho, P.6
  • 68
    • 84858648308 scopus 로고    scopus 로고
    • Vitamin D levels in Chinese patients with systemic lupus erythematosus: relationship with disease activity, vascular risk factors and atherosclerosis
    • [68] Mok, C.C., Birmingham, D.J., Leung, H.W., Hebert, L.A., Song, H., Rovin, B.H., Vitamin D levels in Chinese patients with systemic lupus erythematosus: relationship with disease activity, vascular risk factors and atherosclerosis. Rheumatol. Oxf. 51:4 (2012), 644–652.
    • (2012) Rheumatol. Oxf. , vol.51 , Issue.4 , pp. 644-652
    • Mok, C.C.1    Birmingham, D.J.2    Leung, H.W.3    Hebert, L.A.4    Song, H.5    Rovin, B.H.6
  • 69
    • 84905046025 scopus 로고    scopus 로고
    • 25-hydroxyvitamin D and cardiovascular disease in patients with systemic lupus erythematosus: data from a large international inception cohort
    • [69] Lertratanakul, A., Wu, P., Dyer, A., Urowitz, M., Gladman, D., Fortin, P., et al. 25-hydroxyvitamin D and cardiovascular disease in patients with systemic lupus erythematosus: data from a large international inception cohort. Arthritis Care Res. Hob. 66:8 (2014), 1167–1176.
    • (2014) Arthritis Care Res. Hob. , vol.66 , Issue.8 , pp. 1167-1176
    • Lertratanakul, A.1    Wu, P.2    Dyer, A.3    Urowitz, M.4    Gladman, D.5    Fortin, P.6
  • 70
    • 0035490503 scopus 로고    scopus 로고
    • Bone density and 25-OH vitamin D serum level in patients with systemic lupus erythematosus
    • [70] Becker, A., Fischer, R., Schneider, M., Bone density and 25-OH vitamin D serum level in patients with systemic lupus erythematosus. Z Rheumatol. 60:5 (2001), 352–358.
    • (2001) Z Rheumatol. , vol.60 , Issue.5 , pp. 352-358
    • Becker, A.1    Fischer, R.2    Schneider, M.3
  • 71
    • 80053651571 scopus 로고    scopus 로고
    • Vitamin D deficiency and its association with disease activity in new cases of systemic lupus erythematosus
    • [71] Bonakdar, Z.S., Jahanshahifar, L., Jahanshahifar, F., Gholamrezaei, A., Vitamin D deficiency and its association with disease activity in new cases of systemic lupus erythematosus. Lupus 20:11 (2011), 1155–1160.
    • (2011) Lupus , vol.20 , Issue.11 , pp. 1155-1160
    • Bonakdar, Z.S.1    Jahanshahifar, L.2    Jahanshahifar, F.3    Gholamrezaei, A.4
  • 72
    • 77955293368 scopus 로고    scopus 로고
    • Changes in vitamin D levels in patients with systemic lupus erythematosus: effects on fatigue, disease activity, and damage
    • [72] Ruiz-Irastorza, G., Gordo, S., Olivares, N., Egurbide, M.V., Aguirre, C., Changes in vitamin D levels in patients with systemic lupus erythematosus: effects on fatigue, disease activity, and damage. Arthritis Care Res. Hob. 62:8 (2010), 1160–1165.
    • (2010) Arthritis Care Res. Hob. , vol.62 , Issue.8 , pp. 1160-1165
    • Ruiz-Irastorza, G.1    Gordo, S.2    Olivares, N.3    Egurbide, M.V.4    Aguirre, C.5
  • 73
    • 84867448448 scopus 로고    scopus 로고
    • Restoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementation
    • [73] Terrier, B., Derian, N., Schoindre, Y., Chaara, W., Geri, G., Zahr, N., et al. Restoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementation. Arthritis Res. Ther., 14(5), 2012, R221.
    • (2012) Arthritis Res. Ther. , vol.14 , Issue.5 , pp. R221
    • Terrier, B.1    Derian, N.2    Schoindre, Y.3    Chaara, W.4    Geri, G.5    Zahr, N.6
  • 74
    • 84879867151 scopus 로고    scopus 로고
    • Vitamin D in systemic lupus erythematosus: modest association with disease activity and the urine protein-to-creatinine ratio
    • [74] Petri, M., Bello, K.J., Fang, H., Magder, L.S., Vitamin D in systemic lupus erythematosus: modest association with disease activity and the urine protein-to-creatinine ratio. Arthritis Rheum. 65:7 (2013), 1865–1871.
    • (2013) Arthritis Rheum. , vol.65 , Issue.7 , pp. 1865-1871
    • Petri, M.1    Bello, K.J.2    Fang, H.3    Magder, L.S.4
  • 75
    • 84874881209 scopus 로고    scopus 로고
    • The effect of vitamin D supplementation on inflammatory and hemostatic markers and disease activity in patients with systemic lupus erythematosus: a randomized placebo-controlled trial
    • [75] Abou-Raya, A., Abou-Raya, S., Helmii, M., The effect of vitamin D supplementation on inflammatory and hemostatic markers and disease activity in patients with systemic lupus erythematosus: a randomized placebo-controlled trial. J. Rheumatol. 40:3 (2013), 265–272.
    • (2013) J. Rheumatol. , vol.40 , Issue.3 , pp. 265-272
    • Abou-Raya, A.1    Abou-Raya, S.2    Helmii, M.3
  • 76
    • 84956646097 scopus 로고    scopus 로고
    • Vitamin D supplementation in adolescents and young adults with juvenile systemic lupus erythematosus for improvement in disease activity and fatigue scores: a randomized, double-blind, placebo-controlled trial
    • [76] Lima, G.L., Paupitz, J., Aikawa, N.E., Takayama, L., Bonfa, E., Pereira, R.M., Vitamin D supplementation in adolescents and young adults with juvenile systemic lupus erythematosus for improvement in disease activity and fatigue scores: a randomized, double-blind, placebo-controlled trial. Arthritis Care Res. Hob. 68:1 (2016), 91–98.
    • (2016) Arthritis Care Res. Hob. , vol.68 , Issue.1 , pp. 91-98
    • Lima, G.L.1    Paupitz, J.2    Aikawa, N.E.3    Takayama, L.4    Bonfa, E.5    Pereira, R.M.6
  • 77
    • 84925642865 scopus 로고    scopus 로고
    • A 24-month prospective study on the efficacy and safety of two different monthly regimens of vitamin D supplementation in pre-menopausal women with systemic lupus erythematosus
    • [77] Andreoli, L., Dall'Ara, F., Piantoni, S., Zanola, A., Piva, N., Cutolo, M., et al. A 24-month prospective study on the efficacy and safety of two different monthly regimens of vitamin D supplementation in pre-menopausal women with systemic lupus erythematosus. Lupus 24:4–5 (2015), 499–506.
    • (2015) Lupus , vol.24 , Issue.4-5 , pp. 499-506
    • Andreoli, L.1    Dall'Ara, F.2    Piantoni, S.3    Zanola, A.4    Piva, N.5    Cutolo, M.6
  • 78
    • 56349169572 scopus 로고    scopus 로고
    • Prevalence of hypovitaminosis D in cardiovascular diseases (from the national health and nutrition examination survey 2001 to 2004)
    • [78] Kim, D.H., Sabour, S., Sagar, U.N., Adams, S., Whellan, D.J., Prevalence of hypovitaminosis D in cardiovascular diseases (from the national health and nutrition examination survey 2001 to 2004). Am. J. Cardiol. 102:11 (2008), 1540–1544.
    • (2008) Am. J. Cardiol. , vol.102 , Issue.11 , pp. 1540-1544
    • Kim, D.H.1    Sabour, S.2    Sagar, U.N.3    Adams, S.4    Whellan, D.J.5
  • 80
    • 67349254810 scopus 로고    scopus 로고
    • 25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey
    • [80] Kendrick, J., Targher, G., Smits, G., Chonchol, M., 25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. Atherosclerosis 205:1 (2009), 255–260.
    • (2009) Atherosclerosis , vol.205 , Issue.1 , pp. 255-260
    • Kendrick, J.1    Targher, G.2    Smits, G.3    Chonchol, M.4
  • 81
    • 84866943488 scopus 로고    scopus 로고
    • Premature atherosclerosis is associated with hypovitaminosis D and angiotensin-converting enzyme inhibitor non-use in lupus patients
    • [81] Ravenell, R.L., Kamen, D.L., Spence, J.D., Hollis, B.W., Fleury, T.J., Janech, M.G., et al. Premature atherosclerosis is associated with hypovitaminosis D and angiotensin-converting enzyme inhibitor non-use in lupus patients. Am. J. Med. Sci. 344:4 (2012), 268–273.
    • (2012) Am. J. Med. Sci. , vol.344 , Issue.4 , pp. 268-273
    • Ravenell, R.L.1    Kamen, D.L.2    Spence, J.D.3    Hollis, B.W.4    Fleury, T.J.5    Janech, M.G.6
  • 83
    • 0026074414 scopus 로고
    • A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus
    • [83] A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus. N. Engl. J. Med. 324:3 (1991), 150–154.
    • (1991) N. Engl. J. Med. , vol.324 , Issue.3 , pp. 150-154
  • 84
    • 34548190213 scopus 로고    scopus 로고
    • Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L)
    • [84] Alarcón, G.S., McGwin, G., Bertoli, A.M., Fessler, B.J., Calvo-Alén, J., Bastian, H.M., et al. Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L). Ann. Rheum. Dis. 66:9 (2007), 1168–1172.
    • (2007) Ann. Rheum. Dis. , vol.66 , Issue.9 , pp. 1168-1172
    • Alarcón, G.S.1    McGwin, G.2    Bertoli, A.M.3    Fessler, B.J.4    Calvo-Alén, J.5    Bastian, H.M.6
  • 85
    • 84867498972 scopus 로고    scopus 로고
    • Hydroxychloroquine reduces low-density lipoprotein cholesterol levels in systemic lupus erythematosus: a longitudinal evaluation of the lipid-lowering effect
    • [85] Cairoli, E., Rebella, M., Danese, N., Garra, V., Borba, E.F., Hydroxychloroquine reduces low-density lipoprotein cholesterol levels in systemic lupus erythematosus: a longitudinal evaluation of the lipid-lowering effect. Lupus 21:11 (2012), 1178–1182.
    • (2012) Lupus , vol.21 , Issue.11 , pp. 1178-1182
    • Cairoli, E.1    Rebella, M.2    Danese, N.3    Garra, V.4    Borba, E.F.5
  • 86
    • 33750955870 scopus 로고    scopus 로고
    • Hydroxychloroquine in lupus pregnancy
    • [86] Clowse, M.E., Magder, L., Witter, F., Petri, M., Hydroxychloroquine in lupus pregnancy. Arthritis Rheum. 54:11 (2006), 3640–3647.
    • (2006) Arthritis Rheum. , vol.54 , Issue.11 , pp. 3640-3647
    • Clowse, M.E.1    Magder, L.2    Witter, F.3    Petri, M.4
  • 87
    • 0027931521 scopus 로고
    • Comparison of hydroxychloroquine and placebo in the treatment of the arthropathy of mild systemic lupus erythematosus
    • [87] Williams, H.J., Egger, M.J., Singer, J.Z., Willkens, R.F., Kalunian, K.C., Clegg, D.O., et al. Comparison of hydroxychloroquine and placebo in the treatment of the arthropathy of mild systemic lupus erythematosus. J. Rheumatol. 21:8 (1994), 1457–1462.
    • (1994) J. Rheumatol. , vol.21 , Issue.8 , pp. 1457-1462
    • Williams, H.J.1    Egger, M.J.2    Singer, J.Z.3    Willkens, R.F.4    Kalunian, K.C.5    Clegg, D.O.6
  • 88
    • 0036123462 scopus 로고    scopus 로고
    • Hydroxychloroquine reverses platelet activation induced by human IgG antiphospholipid antibodies
    • [88] Espinola, R.G., Pierangeli, S.S., Gharavi, A.E., Harris, E.N., Ghara, A.E., Hydroxychloroquine reverses platelet activation induced by human IgG antiphospholipid antibodies. Thromb. Haemost. 87:3 (2002), 518–522.
    • (2002) Thromb. Haemost. , vol.87 , Issue.3 , pp. 518-522
    • Espinola, R.G.1    Pierangeli, S.S.2    Gharavi, A.E.3    Harris, E.N.4    Ghara, A.E.5
  • 89
    • 33745849739 scopus 로고    scopus 로고
    • Hydroxychloroquine use predicts complete renal remission within 12 months among patients treated with mycophenolate mofetil therapy for membranous lupus nephritis
    • [89] Kasitanon, N., Fine, D.M., Haas, M., Magder, L.S., Petri, M., Hydroxychloroquine use predicts complete renal remission within 12 months among patients treated with mycophenolate mofetil therapy for membranous lupus nephritis. Lupus 15:6 (2006), 366–370.
    • (2006) Lupus , vol.15 , Issue.6 , pp. 366-370
    • Kasitanon, N.1    Fine, D.M.2    Haas, M.3    Magder, L.S.4    Petri, M.5
  • 90
    • 18644363912 scopus 로고    scopus 로고
    • Systemic lupus erythematosus in three ethnic groups: XVI. Association of hydroxychloroquine use with reduced risk of damage accrual
    • [90] Fessler, B.J., Alarcón, G.S., McGwin, G., Roseman, J., Bastian, H.M., Friedman, A.W., et al. Systemic lupus erythematosus in three ethnic groups: XVI. Association of hydroxychloroquine use with reduced risk of damage accrual. Arthritis Rheum. 52:5 (2005), 1473–1480.
    • (2005) Arthritis Rheum. , vol.52 , Issue.5 , pp. 1473-1480
    • Fessler, B.J.1    Alarcón, G.S.2    McGwin, G.3    Roseman, J.4    Bastian, H.M.5    Friedman, A.W.6
  • 91
    • 84889574291 scopus 로고    scopus 로고
    • The systemic lupus international collaborating clinics (SLICC) damage index: a systematic literature review
    • [91] Sutton, E.J., Davidson, J.E., Bruce, I.N., The systemic lupus international collaborating clinics (SLICC) damage index: a systematic literature review. Semin. Arthritis Rheum. 43:3 (2013), 352–361.
    • (2013) Semin. Arthritis Rheum. , vol.43 , Issue.3 , pp. 352-361
    • Sutton, E.J.1    Davidson, J.E.2    Bruce, I.N.3
  • 92
    • 81155134221 scopus 로고    scopus 로고
    • Cutaneous lupus erythematosus: update of therapeutic options part I
    • [92] Kuhn, A., Ruland, V., Bonsmann, G., Cutaneous lupus erythematosus: update of therapeutic options part I. J. Am. Acad. Dermatol 65:6 (2011), e179–e193.
    • (2011) J. Am. Acad. Dermatol , vol.65 , Issue.6 , pp. e179-e193
    • Kuhn, A.1    Ruland, V.2    Bonsmann, G.3
  • 93
    • 79551544891 scopus 로고    scopus 로고
    • Use of hydroxychloroquine to prevent thrombosis in systemic lupus erythematosus and in antiphospholipid antibody-positive patients
    • [93] Petri, M., Use of hydroxychloroquine to prevent thrombosis in systemic lupus erythematosus and in antiphospholipid antibody-positive patients. Curr. Rheumatol. Rep. 13:1 (2011), 77–80.
    • (2011) Curr. Rheumatol. Rep. , vol.13 , Issue.1 , pp. 77-80
    • Petri, M.1
  • 94
    • 58849159669 scopus 로고    scopus 로고
    • Risk and protective factors for thrombosis in systemic lupus erythematosus: results from a large, multi-ethnic cohort
    • [94] Kaiser, R., Cleveland, C.M., Criswell, L.A., Risk and protective factors for thrombosis in systemic lupus erythematosus: results from a large, multi-ethnic cohort. Ann. Rheum. Dis. 68:2 (2009), 238–241.
    • (2009) Ann. Rheum. Dis. , vol.68 , Issue.2 , pp. 238-241
    • Kaiser, R.1    Cleveland, C.M.2    Criswell, L.A.3
  • 95
    • 58349097555 scopus 로고    scopus 로고
    • Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies
    • [95] Tektonidou, M.G., Laskari, K., Panagiotakos, D.B., Moutsopoulos, H.M., Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies. Arthritis Rheum. 61:1 (2009), 29–36.
    • (2009) Arthritis Rheum. , vol.61 , Issue.1 , pp. 29-36
    • Tektonidou, M.G.1    Laskari, K.2    Panagiotakos, D.B.3    Moutsopoulos, H.M.4
  • 96
    • 0026329304 scopus 로고
    • Frequency of lupus flare in pregnancy. The Hopkins lupus pregnancy center experience
    • [96] Petri, M., Howard, D., Repke, J., Frequency of lupus flare in pregnancy. The Hopkins lupus pregnancy center experience. Arthritis Rheum. 34:12 (1991), 1538–1545.
    • (1991) Arthritis Rheum. , vol.34 , Issue.12 , pp. 1538-1545
    • Petri, M.1    Howard, D.2    Repke, J.3
  • 97
    • 84933670410 scopus 로고    scopus 로고
    • The efficacy of hydroxychloroquine for obstetrical outcome in anti-phospholipid syndrome: data from a European multicenter retrospective study
    • [97] Mekinian, A., Lazzaroni, M.G., Kuzenko, A., Alijotas-Reig, J., Ruffatti, A., Levy, P., et al. The efficacy of hydroxychloroquine for obstetrical outcome in anti-phospholipid syndrome: data from a European multicenter retrospective study. Autoimmun. Rev. 14:6 (2015), 498–502.
    • (2015) Autoimmun. Rev. , vol.14 , Issue.6 , pp. 498-502
    • Mekinian, A.1    Lazzaroni, M.G.2    Kuzenko, A.3    Alijotas-Reig, J.4    Ruffatti, A.5    Levy, P.6
  • 98
    • 84997685666 scopus 로고    scopus 로고
    • Associations of hydroxychloroquine use with lipid profiles in rheumatoid arthritis: pharmacologic implications
    • Nov
    • [98] Kerr, G., Aujero, M., Richards, J., Sayles, H., Davis, L., Cannon, G., et al. Associations of hydroxychloroquine use with lipid profiles in rheumatoid arthritis: pharmacologic implications. Arthritis Care Res. (Hoboken) 66:11 (2014 Nov), 1619–1626, 10.1002/acr.22341.
    • (2014) Arthritis Care Res. (Hoboken) , vol.66 , Issue.11 , pp. 1619-1626
    • Kerr, G.1    Aujero, M.2    Richards, J.3    Sayles, H.4    Davis, L.5    Cannon, G.6
  • 99
    • 84982106637 scopus 로고    scopus 로고
    • Longitudinal evaluation of lipoprotein variables in systemic lupus erythematosus reveals adverse changes with disease activity and prednisone and more favorable profiles with hydroxychloroquine therapy
    • Apr
    • [99] Durcan, L., Winegar, D.A., Connelly, M.A., Otvos, J.D., Magder, L.S., Petri, M., Longitudinal evaluation of lipoprotein variables in systemic lupus erythematosus reveals adverse changes with disease activity and prednisone and more favorable profiles with hydroxychloroquine therapy. J. Rheumatol. 43:4 (2016 Apr), 745–750, 10.3899/jrheum.150437.
    • (2016) J. Rheumatol. , vol.43 , Issue.4 , pp. 745-750
    • Durcan, L.1    Winegar, D.A.2    Connelly, M.A.3    Otvos, J.D.4    Magder, L.S.5    Petri, M.6
  • 100
    • 84866103485 scopus 로고    scopus 로고
    • New insights into mechanisms of therapeutic effects of antimalarial agents in SLE
    • [100] Wallace, D.J., Gudsoorkar, V.S., Weisman, M.H., Venuturupalli, S.R., New insights into mechanisms of therapeutic effects of antimalarial agents in SLE. Nat. Rev. Rheumatol. 8:9 (2012), 522–533.
    • (2012) Nat. Rev. Rheumatol. , vol.8 , Issue.9 , pp. 522-533
    • Wallace, D.J.1    Gudsoorkar, V.S.2    Weisman, M.H.3    Venuturupalli, S.R.4
  • 101
    • 0036175209 scopus 로고    scopus 로고
    • The effectiveness of hydroxychloroquine in patients with type 2 diabetes mellitus who are refractory to sulfonylureas–a randomized trial
    • [101] Gerstein, H.C., Thorpe, K.E., Taylor, D.W., Haynes, R.B., The effectiveness of hydroxychloroquine in patients with type 2 diabetes mellitus who are refractory to sulfonylureas–a randomized trial. Diabetes Res. Clin. Pract. 55:3 (2002), 209–219.
    • (2002) Diabetes Res. Clin. Pract. , vol.55 , Issue.3 , pp. 209-219
    • Gerstein, H.C.1    Thorpe, K.E.2    Taylor, D.W.3    Haynes, R.B.4
  • 102
    • 34547208786 scopus 로고    scopus 로고
    • Hydroxychloroquine sulfate treatment is associated with later onset of systemic lupus erythematosus
    • [102] James, J.A., Kim-Howard, X.R., Bruner, B.F., Jonsson, M.K., McClain, M.T., Arbuckle, M.R., et al. Hydroxychloroquine sulfate treatment is associated with later onset of systemic lupus erythematosus. Lupus 16:6 (2007), 401–409.
    • (2007) Lupus , vol.16 , Issue.6 , pp. 401-409
    • James, J.A.1    Kim-Howard, X.R.2    Bruner, B.F.3    Jonsson, M.K.4    McClain, M.T.5    Arbuckle, M.R.6
  • 103
    • 77957278745 scopus 로고    scopus 로고
    • Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine
    • [103] Izmirly, P.M., Kim, M.Y., Llanos, C., Le, P.U., Guerra, M.M., Askanase, A.D., et al. Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine. Ann. Rheum. Dis. 69:10 (2010), 1827–1830.
    • (2010) Ann. Rheum. Dis. , vol.69 , Issue.10 , pp. 1827-1830
    • Izmirly, P.M.1    Kim, M.Y.2    Llanos, C.3    Le, P.U.4    Guerra, M.M.5    Askanase, A.D.6
  • 104
    • 84863625124 scopus 로고    scopus 로고
    • Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody-associated cardiac manifestations of neonatal lupus
    • [104] Izmirly, P.M., Costedoat-Chalumeau, N., Pisoni, C.N., Khamashta, M.A., Kim, M.Y., Saxena, A., et al. Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody-associated cardiac manifestations of neonatal lupus. Circulation 126:1 (2012), 76–82.
    • (2012) Circulation , vol.126 , Issue.1 , pp. 76-82
    • Izmirly, P.M.1    Costedoat-Chalumeau, N.2    Pisoni, C.N.3    Khamashta, M.A.4    Kim, M.Y.5    Saxena, A.6
  • 105
    • 0031038229 scopus 로고    scopus 로고
    • Chloroquine and hydroxychloroquine equally affect tumor necrosis factor-alpha, interleukin 6, and interferon-gamma production by peripheral blood mononuclear cells
    • [105] van den Borne, B.E., Dijkmans, B.A., de Rooij, H.H., le Cessie, S., Verweij, C.L., Chloroquine and hydroxychloroquine equally affect tumor necrosis factor-alpha, interleukin 6, and interferon-gamma production by peripheral blood mononuclear cells. J. Rheumatol. 24:1 (1997), 55–60.
    • (1997) J. Rheumatol. , vol.24 , Issue.1 , pp. 55-60
    • van den Borne, B.E.1    Dijkmans, B.A.2    de Rooij, H.H.3    le Cessie, S.4    Verweij, C.L.5
  • 106
    • 0032033594 scopus 로고    scopus 로고
    • Antimalarial drugs inhibit phospholipase A2 activation and induction of interleukin 1beta and tumor necrosis factor alpha in macrophages: implications for their mode of action in rheumatoid arthritis
    • [106] Bondeson, J., Sundler, R., Antimalarial drugs inhibit phospholipase A2 activation and induction of interleukin 1beta and tumor necrosis factor alpha in macrophages: implications for their mode of action in rheumatoid arthritis. Gen. Pharmacol. 30:3 (1998), 357–366.
    • (1998) Gen. Pharmacol. , vol.30 , Issue.3 , pp. 357-366
    • Bondeson, J.1    Sundler, R.2
  • 107
    • 84879317702 scopus 로고    scopus 로고
    • Hydroxychloroquine decreases Th17-related cytokines in systemic lupus erythematosus and rheumatoid arthritis patients
    • [107] Silva, J.C., Mariz, H.A., Rocha, L.F., Oliveira, P.S., Dantas, A.T., Duarte, A.L., et al. Hydroxychloroquine decreases Th17-related cytokines in systemic lupus erythematosus and rheumatoid arthritis patients. Clin. (Sao Paulo) 68:6 (2013), 766–771.
    • (2013) Clin. (Sao Paulo) , vol.68 , Issue.6 , pp. 766-771
    • Silva, J.C.1    Mariz, H.A.2    Rocha, L.F.3    Oliveira, P.S.4    Dantas, A.T.5    Duarte, A.L.6
  • 108
    • 84862752020 scopus 로고    scopus 로고
    • Hydroxychloroquine is associated with impaired interferon-alpha and tumor necrosis factor-alpha production by plasmacytoid dendritic cells in systemic lupus erythematosus
    • [108] Sacre, K., Criswell, L.A., McCune, J.M., Hydroxychloroquine is associated with impaired interferon-alpha and tumor necrosis factor-alpha production by plasmacytoid dendritic cells in systemic lupus erythematosus. Arthritis Res. Ther., 14(3), 2012, R155.
    • (2012) Arthritis Res. Ther. , vol.14 , Issue.3 , pp. R155
    • Sacre, K.1    Criswell, L.A.2    McCune, J.M.3
  • 109
    • 84861835445 scopus 로고    scopus 로고
    • Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: data from LUMINA (LXXV), a multiethnic US cohort
    • [109] Willis, R., Seif, A.M., McGwin, G., Martinez-Martinez, L.A., González, E.B., Dang, N., et al. Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: data from LUMINA (LXXV), a multiethnic US cohort. Lupus 21:8 (2012), 830–835.
    • (2012) Lupus , vol.21 , Issue.8 , pp. 830-835
    • Willis, R.1    Seif, A.M.2    McGwin, G.3    Martinez-Martinez, L.A.4    González, E.B.5    Dang, N.6
  • 110
    • 0000391671 scopus 로고
    • Decrease in macrophage antigen catabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells
    • [110] Ziegler, H.K., Unanue, E.R., Decrease in macrophage antigen catabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells. Proc. Natl. Acad. Sci. U. S. A. 79:1 (1982), 175–178.
    • (1982) Proc. Natl. Acad. Sci. U. S. A. , vol.79 , Issue.1 , pp. 175-178
    • Ziegler, H.K.1    Unanue, E.R.2
  • 112
    • 33750297108 scopus 로고    scopus 로고
    • Antimalarial agents: closing the gate on Toll-like receptors?
    • [112] Lafyatis, R., York, M., Marshak-Rothstein, A., Antimalarial agents: closing the gate on Toll-like receptors?. Arthritis Rheum. 54:10 (2006), 3068–3070.
    • (2006) Arthritis Rheum. , vol.54 , Issue.10 , pp. 3068-3070
    • Lafyatis, R.1    York, M.2    Marshak-Rothstein, A.3
  • 113
    • 84928484966 scopus 로고    scopus 로고
    • Cutting edge: antimalarial drugs inhibit IFN-β production through blockade of cyclic GMP-AMP synthase-DNA interaction
    • [113] An, J., Woodward, J.J., Sasaki, T., Minie, M., Elkon, K.B., Cutting edge: antimalarial drugs inhibit IFN-β production through blockade of cyclic GMP-AMP synthase-DNA interaction. J. Immunol. 194:9 (2015), 4089–4093.
    • (2015) J. Immunol. , vol.194 , Issue.9 , pp. 4089-4093
    • An, J.1    Woodward, J.J.2    Sasaki, T.3    Minie, M.4    Elkon, K.B.5
  • 114
    • 0026074414 scopus 로고
    • A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group
    • [114] A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group. N. Engl. J. Med. 324:3 (1991), 150–154.
    • (1991) N. Engl. J. Med. , vol.324 , Issue.3 , pp. 150-154
  • 115
    • 84881360370 scopus 로고    scopus 로고
    • Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials
    • [115] Petri, M.A., van Vollenhoven, R.F., Buyon, J., Levy, R.A., Navarra, S.V., Cervera, R., et al. Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials. Arthritis Rheum. 65:8 (2013), 2143–2153.
    • (2013) Arthritis Rheum. , vol.65 , Issue.8 , pp. 2143-2153
    • Petri, M.A.1    van Vollenhoven, R.F.2    Buyon, J.3    Levy, R.A.4    Navarra, S.V.5    Cervera, R.6
  • 116
    • 33750302628 scopus 로고    scopus 로고
    • Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus
    • [116] Costedoat-Chalumeau, N., Amoura, Z., Hulot, J.S., Hammoud, H.A., Aymard, G., Cacoub, P., et al. Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus. Arthritis Rheum. 54:10 (2006), 3284–3290.
    • (2006) Arthritis Rheum. , vol.54 , Issue.10 , pp. 3284-3290
    • Costedoat-Chalumeau, N.1    Amoura, Z.2    Hulot, J.S.3    Hammoud, H.A.4    Aymard, G.5    Cacoub, P.6
  • 117
    • 84859992864 scopus 로고    scopus 로고
    • Low blood concentration of hydroxychloroquine in patients with refractory cutaneous lupus erythematosus: a French multicenter prospective study
    • [117] Francès, C., Cosnes, A., Duhaut, P., Zahr, N., Soutou, B., Ingen-Housz-Oro, S., et al. Low blood concentration of hydroxychloroquine in patients with refractory cutaneous lupus erythematosus: a French multicenter prospective study. Arch. Dermatol 148:4 (2012), 479–484.
    • (2012) Arch. Dermatol , vol.148 , Issue.4 , pp. 479-484
    • Francès, C.1    Cosnes, A.2    Duhaut, P.3    Zahr, N.4    Soutou, B.5    Ingen-Housz-Oro, S.6
  • 118
    • 84881322752 scopus 로고    scopus 로고
    • Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)
    • [118] Costedoat-Chalumeau, N., Galicier, L., Aumaitre, O., Frances, C., Le Guern, V., Liote, F., et al. Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study). Ann. Rheum. Dis. 72:11 (2013), 1786–1792.
    • (2013) Ann. Rheum. Dis. , vol.72 , Issue.11 , pp. 1786-1792
    • Costedoat-Chalumeau, N.1    Galicier, L.2    Aumaitre, O.3    Frances, C.4    Le Guern, V.5    Liote, F.6
  • 119
    • 84946606371 scopus 로고    scopus 로고
    • Hydroxychloroquine blood levels in SLE: clarifying dosing controversies and improving adherence
    • Nov
    • [119] Durcan, L., Clarke, W.A., Magder, L.S., Petri, M., Hydroxychloroquine blood levels in SLE: clarifying dosing controversies and improving adherence. J. Rheumatol. 42:11 (2015 Nov), 2092–2097, 10.3899/jrheum.150379.
    • (2015) J. Rheumatol. , vol.42 , Issue.11 , pp. 2092-2097
    • Durcan, L.1    Clarke, W.A.2    Magder, L.S.3    Petri, M.4
  • 120
    • 0027931521 scopus 로고
    • Comparison of hydroxychloroquine and placebo in the treatment of the arthropathy of mild systemic lupus erythematosus
    • [120] Williams, H.J., Egger, M.J., Singer, J.Z., Willkens, R.F., Kalunian, K.C., Clegg, D.O., et al. Comparison of hydroxychloroquine and placebo in the treatment of the arthropathy of mild systemic lupus erythematosus. J. Rheumatol. 21:8 (1994), 1457–1462.
    • (1994) J. Rheumatol. , vol.21 , Issue.8 , pp. 1457-1462
    • Williams, H.J.1    Egger, M.J.2    Singer, J.Z.3    Willkens, R.F.4    Kalunian, K.C.5    Clegg, D.O.6
  • 121
    • 84881557131 scopus 로고    scopus 로고
    • Preventing congenital neonatal heart block in offspring of mothers with anti-SSA/Ro and SSB/La antibodies: a review of published literature and registered clinical trials
    • [121] Gleicher, N., Elkayam, U., Preventing congenital neonatal heart block in offspring of mothers with anti-SSA/Ro and SSB/La antibodies: a review of published literature and registered clinical trials. Autoimmun. Rev. 12:11 (2013), 1039–1045.
    • (2013) Autoimmun. Rev. , vol.12 , Issue.11 , pp. 1039-1045
    • Gleicher, N.1    Elkayam, U.2
  • 122
    • 77949879784 scopus 로고    scopus 로고
    • Ro60-associated single-stranded RNA links inflammation with fetal cardiac fibrosis via ligation of TLRs: a novel pathway to autoimmune-associated heart block
    • [122] Clancy, R.M., Alvarez, D., Komissarova, E., Barrat, F.J., Swartz, J., Buyon, J.P., Ro60-associated single-stranded RNA links inflammation with fetal cardiac fibrosis via ligation of TLRs: a novel pathway to autoimmune-associated heart block. J. Immunol. 184:4 (2010), 2148–2155.
    • (2010) J. Immunol. , vol.184 , Issue.4 , pp. 2148-2155
    • Clancy, R.M.1    Alvarez, D.2    Komissarova, E.3    Barrat, F.J.4    Swartz, J.5    Buyon, J.P.6
  • 123
    • 84918584162 scopus 로고    scopus 로고
    • The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy
    • [123] Melles, R.B., Marmor, M.F., The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy. JAMA Ophthalmol. 132:12 (2014), 1453–1460.
    • (2014) JAMA Ophthalmol. , vol.132 , Issue.12 , pp. 1453-1460
    • Melles, R.B.1    Marmor, M.F.2
  • 124
    • 79551548116 scopus 로고    scopus 로고
    • Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy
    • [124] Marmor, M.F., Kellner, U., Lai, T.Y., Lyons, J.S., Mieler, W.F., Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy. Ophthalmology 118:2 (2011), 415–422.
    • (2011) Ophthalmology , vol.118 , Issue.2 , pp. 415-422
    • Marmor, M.F.1    Kellner, U.2    Lai, T.Y.3    Lyons, J.S.4    Mieler, W.F.5
  • 125
  • 126
    • 84883257895 scopus 로고    scopus 로고
    • Efficacy and safety of ocrelizumab in active proliferative lupus nephritis: results from a randomized, double-blind, phase III study
    • [126] Mysler, E.F., Spindler, A.J., Guzman, R., Bijl, M., Jayne, D., Furie, R.A., et al. Efficacy and safety of ocrelizumab in active proliferative lupus nephritis: results from a randomized, double-blind, phase III study. Arthritis Rheum. 65:9 (2013), 2368–2379.
    • (2013) Arthritis Rheum. , vol.65 , Issue.9 , pp. 2368-2379
    • Mysler, E.F.1    Spindler, A.J.2    Guzman, R.3    Bijl, M.4    Jayne, D.5    Furie, R.A.6
  • 127
    • 74849131972 scopus 로고    scopus 로고
    • Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial
    • [127] Merrill, J.T., Neuwelt, C.M., Wallace, D.J., Shanahan, J.C., Latinis, K.M., Oates, J.C., et al. Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial. Arthritis Rheum. 62:1 (2010), 222–233.
    • (2010) Arthritis Rheum. , vol.62 , Issue.1 , pp. 222-233
    • Merrill, J.T.1    Neuwelt, C.M.2    Wallace, D.J.3    Shanahan, J.C.4    Latinis, K.M.5    Oates, J.C.6
  • 128
    • 84879502096 scopus 로고    scopus 로고
    • Efficacy and safety of epratuzumab in patients with moderate/severe flaring systemic lupus erythematosus: results from two randomized, double-blind, placebo-controlled, multicentre studies (ALLEVIATE) and follow-up
    • [128] Wallace, D.J., Gordon, C., Strand, V., Hobbs, K., Petri, M., Kalunian, K., et al. Efficacy and safety of epratuzumab in patients with moderate/severe flaring systemic lupus erythematosus: results from two randomized, double-blind, placebo-controlled, multicentre studies (ALLEVIATE) and follow-up. Rheumatol. Oxf. 52:7 (2013), 1313–1322.
    • (2013) Rheumatol. Oxf. , vol.52 , Issue.7 , pp. 1313-1322
    • Wallace, D.J.1    Gordon, C.2    Strand, V.3    Hobbs, K.4    Petri, M.5    Kalunian, K.6
  • 129
    • 82455198794 scopus 로고    scopus 로고
    • A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
    • [129] Furie, R., Petri, M., Zamani, O., Cervera, R., Wallace, D.J., Tegzová, D., et al. A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus. Arthritis Rheum. 63:12 (2011), 3918–3930.
    • (2011) Arthritis Rheum. , vol.63 , Issue.12 , pp. 3918-3930
    • Furie, R.1    Petri, M.2    Zamani, O.3    Cervera, R.4    Wallace, D.J.5    Tegzová, D.6
  • 130
    • 84942111128 scopus 로고    scopus 로고
    • A phase 2, randomised, placebo-controlled clinical trial of blisibimod, an inhibitor of B cell activating factor, in patients with moderate-to-severe systemic lupus erythematosus, the PEARL-SC study
    • [130] Furie, R.A., Leon, G., Thomas, M., Petri, M.A., Chu, A.D., Hislop, C., et al. A phase 2, randomised, placebo-controlled clinical trial of blisibimod, an inhibitor of B cell activating factor, in patients with moderate-to-severe systemic lupus erythematosus, the PEARL-SC study. Ann. Rheum. Dis. 74:9 (2015), 1667–1675.
    • (2015) Ann. Rheum. Dis. , vol.74 , Issue.9 , pp. 1667-1675
    • Furie, R.A.1    Leon, G.2    Thomas, M.3    Petri, M.A.4    Chu, A.D.5    Hislop, C.6
  • 131
    • 84954302328 scopus 로고    scopus 로고
    • Efficacy and safety of subcutaneous tabalumab in patients with systemic lupus erythematosus: results from ILLUMINATE-1, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study
    • [131] Isenberg, D.A., Petri, M., Kalunian, K., Tanaka, Y., Urowitz, M.B., Hoffman, R.W., et al. Efficacy and safety of subcutaneous tabalumab in patients with systemic lupus erythematosus: results from ILLUMINATE-1, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study. Ann. Rheum. Dis. 75:2 (2016), 323–331.
    • (2016) Ann. Rheum. Dis. , vol.75 , Issue.2 , pp. 323-331
    • Isenberg, D.A.1    Petri, M.2    Kalunian, K.3    Tanaka, Y.4    Urowitz, M.B.5    Hoffman, R.W.6
  • 132
    • 84945242898 scopus 로고    scopus 로고
    • Efficacy and safety of atacicept for prevention of flares in patients with moderate-to-severe systemic lupus erythematosus (SLE): 52-week data (APRIL-SLE randomised trial)
    • [132] Isenberg, D., Gordon, C., Licu, D., Copt, S., Rossi, C.P., Wofsy, D., Efficacy and safety of atacicept for prevention of flares in patients with moderate-to-severe systemic lupus erythematosus (SLE): 52-week data (APRIL-SLE randomised trial). Ann. Rheum. Dis. 74:11 (2015), 2006–2015.
    • (2015) Ann. Rheum. Dis. , vol.74 , Issue.11 , pp. 2006-2015
    • Isenberg, D.1    Gordon, C.2    Licu, D.3    Copt, S.4    Rossi, C.P.5    Wofsy, D.6
  • 133
    • 79952070370 scopus 로고    scopus 로고
    • Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
    • [133] Navarra, S.V., Guzmán, R.M., Gallacher, A.E., Hall, S., Levy, R.A., Jimenez, R.E., et al. Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial. Lancet 377:9767 (2011), 721–731.
    • (2011) Lancet , vol.377 , Issue.9767 , pp. 721-731
    • Navarra, S.V.1    Guzmán, R.M.2    Gallacher, A.E.3    Hall, S.4    Levy, R.A.5    Jimenez, R.E.6
  • 134
    • 84862002288 scopus 로고    scopus 로고
    • Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus
    • [134] Stohl, W., Hiepe, F., Latinis, K.M., Thomas, M., Scheinberg, M.A., Clarke, A., et al. Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus. Arthritis Rheum. 64:7 (2012), 2328–2337.
    • (2012) Arthritis Rheum. , vol.64 , Issue.7 , pp. 2328-2337
    • Stohl, W.1    Hiepe, F.2    Latinis, K.M.3    Thomas, M.4    Scheinberg, M.A.5    Clarke, A.6
  • 135
    • 84863850571 scopus 로고    scopus 로고
    • Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response
    • [135] van Vollenhoven, R.F., Petri, M.A., Cervera, R., Roth, D.A., Ji, B.N., Kleoudis, C.S., et al. Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response. Ann. Rheum. Dis. 71:8 (2012), 1343–1349.
    • (2012) Ann. Rheum. Dis. , vol.71 , Issue.8 , pp. 1343-1349
    • van Vollenhoven, R.F.1    Petri, M.A.2    Cervera, R.3    Roth, D.A.4    Ji, B.N.5    Kleoudis, C.S.6
  • 136
    • 84871574493 scopus 로고    scopus 로고
    • Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE
    • [136] Dooley, M.A., Houssiau, F., Aranow, C., D'Cruz, D.P., Askanase, A., Roth, D.A., et al. Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE. Lupus 22:1 (2013), 63–72.
    • (2013) Lupus , vol.22 , Issue.1 , pp. 63-72
    • Dooley, M.A.1    Houssiau, F.2    Aranow, C.3    D'Cruz, D.P.4    Askanase, A.5    Roth, D.A.6
  • 137
    • 82755160832 scopus 로고    scopus 로고
    • Current state and future directions of autologous hematopoietic stem cell transplantation in systemic lupus erythematosus
    • [137] Illei, G.G., Cervera, R., Burt, R.K., Doria, A., Hiepe, F., Jayne, D., et al. Current state and future directions of autologous hematopoietic stem cell transplantation in systemic lupus erythematosus. Ann. Rheum. Dis. 70:12 (2011), 2071–2074.
    • (2011) Ann. Rheum. Dis. , vol.70 , Issue.12 , pp. 2071-2074
    • Illei, G.G.1    Cervera, R.2    Burt, R.K.3    Doria, A.4    Hiepe, F.5    Jayne, D.6
  • 138
    • 78649742723 scopus 로고    scopus 로고
    • Stem cell transplantation: progress in Asia
    • [138] Sun, L., Stem cell transplantation: progress in Asia. Lupus 19:12 (2010), 1468–1473.
    • (2010) Lupus , vol.19 , Issue.12 , pp. 1468-1473
    • Sun, L.1
  • 139
    • 0027199515 scopus 로고
    • Immune ablation with stem-cell rescue: a possible cure for systemic lupus erythematosus?
    • [139] Marmont, A.M., Immune ablation with stem-cell rescue: a possible cure for systemic lupus erythematosus?. Lupus 2:3 (1993), 151–156.
    • (1993) Lupus , vol.2 , Issue.3 , pp. 151-156
    • Marmont, A.M.1
  • 140
    • 11144357974 scopus 로고    scopus 로고
    • Autologous stem cell transplantation for systemic lupus erythematosus
    • [140] Jayne, D., Passweg, J., Marmont, A., Farge, D., Zhao, X., Arnold, R., et al. Autologous stem cell transplantation for systemic lupus erythematosus. Lupus 13:3 (2004), 168–176.
    • (2004) Lupus , vol.13 , Issue.3 , pp. 168-176
    • Jayne, D.1    Passweg, J.2    Marmont, A.3    Farge, D.4    Zhao, X.5    Arnold, R.6
  • 141
    • 0034718372 scopus 로고    scopus 로고
    • Treatment of severe systemic lupus erythematosus with high-dose chemotherapy and haemopoietic stem-cell transplantation: a phase I study
    • [141] Traynor, A.E., Schroeder, J., Rosa, R.M., Cheng, D., Stefka, J., Mujais, S., et al. Treatment of severe systemic lupus erythematosus with high-dose chemotherapy and haemopoietic stem-cell transplantation: a phase I study. Lancet 356:9231 (2000), 701–707.
    • (2000) Lancet , vol.356 , Issue.9231 , pp. 701-707
    • Traynor, A.E.1    Schroeder, J.2    Rosa, R.M.3    Cheng, D.4    Stefka, J.5    Mujais, S.6
  • 142
    • 59449092041 scopus 로고    scopus 로고
    • Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system
    • [142] Alexander, T., Thiel, A., Rosen, O., Massenkeil, G., Sattler, A., Kohler, S., et al. Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system. Blood 113:1 (2009), 214–223.
    • (2009) Blood , vol.113 , Issue.1 , pp. 214-223
    • Alexander, T.1    Thiel, A.2    Rosen, O.3    Massenkeil, G.4    Sattler, A.5    Kohler, S.6
  • 143
    • 76349096767 scopus 로고    scopus 로고
    • Regulatory T cell (Treg) subsets return in patients with refractory lupus following stem cell transplantation, and TGF-beta-producing CD8+ Treg cells are associated with immunological remission of lupus
    • [143] Zhang, L., Bertucci, A.M., Ramsey-Goldman, R., Burt, R.K., Datta, S.K., Regulatory T cell (Treg) subsets return in patients with refractory lupus following stem cell transplantation, and TGF-beta-producing CD8+ Treg cells are associated with immunological remission of lupus. J. Immunol. 183:10 (2009), 6346–6358.
    • (2009) J. Immunol. , vol.183 , Issue.10 , pp. 6346-6358
    • Zhang, L.1    Bertucci, A.M.2    Ramsey-Goldman, R.3    Burt, R.K.4    Datta, S.K.5
  • 144
    • 84904993611 scopus 로고    scopus 로고
    • A CD8 T cell/indoleamine 2,3-dioxygenase axis is required for mesenchymal stem cell suppression of human systemic lupus erythematosus
    • [144] Wang, D., Feng, X., Lu, L., Konkel, J.E., Zhang, H., Chen, Z., et al. A CD8 T cell/indoleamine 2,3-dioxygenase axis is required for mesenchymal stem cell suppression of human systemic lupus erythematosus. Arthritis Rheumatol. 66:8 (2014), 2234–2245.
    • (2014) Arthritis Rheumatol. , vol.66 , Issue.8 , pp. 2234-2245
    • Wang, D.1    Feng, X.2    Lu, L.3    Konkel, J.E.4    Zhang, H.5    Chen, Z.6
  • 145
    • 4444300345 scopus 로고    scopus 로고
    • Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus
    • [145] Petri, M.A., Mease, P.J., Merrill, J.T., Lahita, R.G., Iannini, M.J., Yocum, D.E., et al. Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus. Arthritis Rheum. 50:9 (2004), 2858–2868.
    • (2004) Arthritis Rheum. , vol.50 , Issue.9 , pp. 2858-2868
    • Petri, M.A.1    Mease, P.J.2    Merrill, J.T.3    Lahita, R.G.4    Iannini, M.J.5    Yocum, D.E.6
  • 146
    • 77952793334 scopus 로고    scopus 로고
    • Effects of dehydroepiandrosterone on fatigue and well-being in women with quiescent systemic lupus erythematosus: a randomised controlled trial
    • [146] Hartkamp, A., Geenen, R., Godaert, G.L., Bijl, M., Bijlsma, J.W., Derksen, R.H., Effects of dehydroepiandrosterone on fatigue and well-being in women with quiescent systemic lupus erythematosus: a randomised controlled trial. Ann. Rheum. Dis. 69:6 (2010), 1144–1147.
    • (2010) Ann. Rheum. Dis. , vol.69 , Issue.6 , pp. 1144-1147
    • Hartkamp, A.1    Geenen, R.2    Godaert, G.L.3    Bijl, M.4    Bijlsma, J.W.5    Derksen, R.H.6
  • 147
    • 84925626423 scopus 로고    scopus 로고
    • Phenotype modifications of T-cells and their shift toward a Th2 response in patients with systemic lupus erythematosus supplemented with different monthly regimens of vitamin D
    • [147] Piantoni, S., Andreoli, L., Scarsi, M., Zanola, A., Dall'Ara, F., Pizzorni, C., et al. Phenotype modifications of T-cells and their shift toward a Th2 response in patients with systemic lupus erythematosus supplemented with different monthly regimens of vitamin D. Lupus 24:4–5 (2015), 490–498.
    • (2015) Lupus , vol.24 , Issue.4-5 , pp. 490-498
    • Piantoni, S.1    Andreoli, L.2    Scarsi, M.3    Zanola, A.4    Dall'Ara, F.5    Pizzorni, C.6
  • 148
    • 0034990187 scopus 로고    scopus 로고
    • Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study
    • [148] Levy, R.A., Vilela, V.S., Cataldo, M.J., Ramos, R.C., Duarte, J.L., Tura, B.R., et al. Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study. Lupus 10:6 (2001), 401–404.
    • (2001) Lupus , vol.10 , Issue.6 , pp. 401-404
    • Levy, R.A.1    Vilela, V.S.2    Cataldo, M.J.3    Ramos, R.C.4    Duarte, J.L.5    Tura, B.R.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.